Crescent Capital BDC (CCAP) Competitors

$10.93 0.00 (0.00%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$10.92 -0.01 (-0.09%)

As of 07/31/2026 07:34 PM Eastern

CCAP vs. CGBD, MFIC, SLRC, BCSF, and GSBD

Should you buy Crescent Capital BDC stock or one of its competitors? MarketBeat compares Crescent Capital BDC with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Crescent Capital BDC include Carlyle Secured Lending (CGBD), MidCap Financial Investment (MFIC), SLR Investment (SLRC), Bain Capital Specialty Finance (BCSF), and Goldman Sachs BDC (GSBD). These companies are all part of the "finance" sector.

How does Crescent Capital BDC compare to Carlyle Secured Lending?

Carlyle Secured Lending (NASDAQ:CGBD) and Crescent Capital BDC (NASDAQ:CCAP) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, media sentiment, institutional ownership, analyst recommendations and profitability.

Carlyle Secured Lending pays an annual dividend of $1.40 per share and has a dividend yield of 14.0%. Crescent Capital BDC pays an annual dividend of $1.36 per share and has a dividend yield of 12.4%. Carlyle Secured Lending pays out 197.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC pays out 331.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has increased its dividend for 1 consecutive years. Carlyle Secured Lending is clearly the better dividend stock, given its higher yield and lower payout ratio.

Carlyle Secured Lending has a net margin of 19.52% compared to Crescent Capital BDC's net margin of 9.26%. Crescent Capital BDC's return on equity of 9.34% beat Carlyle Secured Lending's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Carlyle Secured Lending	19.52%	8.99%	4.01%
Crescent Capital BDC	9.26%	9.34%	4.04%

In the previous week, Carlyle Secured Lending had 8 more articles in the media than Crescent Capital BDC. MarketBeat recorded 8 mentions for Carlyle Secured Lending and 0 mentions for Crescent Capital BDC. Carlyle Secured Lending's average media sentiment score of 1.13 beat Crescent Capital BDC's score of 0.00 indicating that Carlyle Secured Lending is being referred to more favorably in the media.

Company	Overall Sentiment
Carlyle Secured Lending	Positive
Crescent Capital BDC	Neutral

Carlyle Secured Lending has a beta of 0.62, meaning that its stock price is 38% less volatile than the broader market. Comparatively, Crescent Capital BDC has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market.

24.5% of Carlyle Secured Lending shares are owned by institutional investors. Comparatively, 49.5% of Crescent Capital BDC shares are owned by institutional investors. 0.4% of Carlyle Secured Lending shares are owned by insiders. Comparatively, 1.2% of Crescent Capital BDC shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Carlyle Secured Lending has higher earnings, but lower revenue than Crescent Capital BDC. Carlyle Secured Lending is trading at a lower price-to-earnings ratio than Crescent Capital BDC, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Carlyle Secured Lending	$63.06M	11.01	$69.97M	$0.71	14.07
Crescent Capital BDC	$167.29M	2.41	$34.51M	$0.41	26.66

Carlyle Secured Lending presently has a consensus price target of $12.50, suggesting a potential upside of 25.13%. Crescent Capital BDC has a consensus price target of $13.90, suggesting a potential upside of 27.17%. Given Crescent Capital BDC's higher possible upside, analysts plainly believe Crescent Capital BDC is more favorable than Carlyle Secured Lending.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Carlyle Secured Lending	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.43
Crescent Capital BDC	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

Carlyle Secured Lending beats Crescent Capital BDC on 11 of the 19 factors compared between the two stocks.

How does Crescent Capital BDC compare to MidCap Financial Investment?

Crescent Capital BDC (NASDAQ:CCAP) and MidCap Financial Investment (NASDAQ:MFIC) are both small-cap finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership.

In the previous week, MidCap Financial Investment had 2 more articles in the media than Crescent Capital BDC. MarketBeat recorded 2 mentions for MidCap Financial Investment and 0 mentions for Crescent Capital BDC. MidCap Financial Investment's average media sentiment score of 0.11 beat Crescent Capital BDC's score of 0.00 indicating that MidCap Financial Investment is being referred to more favorably in the news media.

Company	Overall Sentiment
Crescent Capital BDC	Neutral
MidCap Financial Investment	Neutral

Crescent Capital BDC has a net margin of 9.26% compared to MidCap Financial Investment's net margin of 1.90%. MidCap Financial Investment's return on equity of 10.86% beat Crescent Capital BDC's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Crescent Capital BDC	9.26%	9.34%	4.04%
MidCap Financial Investment	1.90%	10.86%	4.31%

49.5% of Crescent Capital BDC shares are owned by institutional investors. Comparatively, 28.5% of MidCap Financial Investment shares are owned by institutional investors. 1.2% of Crescent Capital BDC shares are owned by company insiders. Comparatively, 0.9% of MidCap Financial Investment shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Crescent Capital BDC currently has a consensus price target of $13.90, suggesting a potential upside of 27.17%. MidCap Financial Investment has a consensus price target of $11.46, suggesting a potential upside of 19.92%. Given Crescent Capital BDC's stronger consensus rating and higher possible upside, equities analysts clearly believe Crescent Capital BDC is more favorable than MidCap Financial Investment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Crescent Capital BDC	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
MidCap Financial Investment	0 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.22

MidCap Financial Investment has higher revenue and earnings than Crescent Capital BDC. Crescent Capital BDC is trading at a lower price-to-earnings ratio than MidCap Financial Investment, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Crescent Capital BDC	$167.29M	2.41	$34.51M	$0.41	26.66
MidCap Financial Investment	$320.88M	2.45	$63.17M	$0.04	239.00

Crescent Capital BDC has a beta of 0.52, indicating that its stock price is 48% less volatile than the broader market. Comparatively, MidCap Financial Investment has a beta of 0.61, indicating that its stock price is 39% less volatile than the broader market.

Crescent Capital BDC pays an annual dividend of $1.36 per share and has a dividend yield of 12.4%. MidCap Financial Investment pays an annual dividend of $1.24 per share and has a dividend yield of 13.0%. Crescent Capital BDC pays out 331.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. MidCap Financial Investment pays out 3,100.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has increased its dividend for 1 consecutive years.

Summary

MidCap Financial Investment beats Crescent Capital BDC on 10 of the 18 factors compared between the two stocks.

How does Crescent Capital BDC compare to SLR Investment?

Crescent Capital BDC (NASDAQ:CCAP) and SLR Investment (NASDAQ:SLRC) are both small-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability, risk and media sentiment.

SLR Investment has higher revenue and earnings than Crescent Capital BDC. SLR Investment is trading at a lower price-to-earnings ratio than Crescent Capital BDC, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Crescent Capital BDC	$167.29M	2.41	$34.51M	$0.41	26.66
SLR Investment	$218.54M	3.14	$92.54M	$1.64	7.67

49.5% of Crescent Capital BDC shares are held by institutional investors. Comparatively, 35.3% of SLR Investment shares are held by institutional investors. 1.2% of Crescent Capital BDC shares are held by insiders. Comparatively, 8.8% of SLR Investment shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Crescent Capital BDC currently has a consensus price target of $13.90, indicating a potential upside of 27.17%. SLR Investment has a consensus price target of $14.10, indicating a potential upside of 12.08%. Given Crescent Capital BDC's stronger consensus rating and higher possible upside, equities research analysts plainly believe Crescent Capital BDC is more favorable than SLR Investment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Crescent Capital BDC	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
SLR Investment	3 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.86

Crescent Capital BDC has a beta of 0.52, indicating that its share price is 48% less volatile than the broader market. Comparatively, SLR Investment has a beta of 0.64, indicating that its share price is 36% less volatile than the broader market.

Crescent Capital BDC pays an annual dividend of $1.36 per share and has a dividend yield of 12.4%. SLR Investment pays an annual dividend of $1.24 per share and has a dividend yield of 9.9%. Crescent Capital BDC pays out 331.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. SLR Investment pays out 75.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has increased its dividend for 1 consecutive years. Crescent Capital BDC is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, SLR Investment had 3 more articles in the media than Crescent Capital BDC. MarketBeat recorded 3 mentions for SLR Investment and 0 mentions for Crescent Capital BDC. SLR Investment's average media sentiment score of 0.24 beat Crescent Capital BDC's score of 0.00 indicating that SLR Investment is being referred to more favorably in the news media.

Company	Overall Sentiment
Crescent Capital BDC	Neutral
SLR Investment	Neutral

SLR Investment has a net margin of 41.81% compared to Crescent Capital BDC's net margin of 9.26%. Crescent Capital BDC's return on equity of 9.34% beat SLR Investment's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Crescent Capital BDC	9.26%	9.34%	4.04%
SLR Investment	41.81%	8.33%	3.25%

Summary

SLR Investment beats Crescent Capital BDC on 10 of the 18 factors compared between the two stocks.

How does Crescent Capital BDC compare to Bain Capital Specialty Finance?

Bain Capital Specialty Finance (NYSE:BCSF) and Crescent Capital BDC (NASDAQ:CCAP) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, analyst recommendations, institutional ownership, media sentiment and dividends.

Bain Capital Specialty Finance has a beta of 0.58, meaning that its share price is 42% less volatile than the broader market. Comparatively, Crescent Capital BDC has a beta of 0.52, meaning that its share price is 48% less volatile than the broader market.

Bain Capital Specialty Finance currently has a consensus target price of $14.00, suggesting a potential upside of 12.93%. Crescent Capital BDC has a consensus target price of $13.90, suggesting a potential upside of 27.17%. Given Crescent Capital BDC's higher probable upside, analysts clearly believe Crescent Capital BDC is more favorable than Bain Capital Specialty Finance.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bain Capital Specialty Finance	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Crescent Capital BDC	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

49.5% of Crescent Capital BDC shares are owned by institutional investors. 0.6% of Bain Capital Specialty Finance shares are owned by company insiders. Comparatively, 1.2% of Crescent Capital BDC shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Bain Capital Specialty Finance pays an annual dividend of $1.68 per share and has a dividend yield of 13.6%. Crescent Capital BDC pays an annual dividend of $1.36 per share and has a dividend yield of 12.4%. Bain Capital Specialty Finance pays out 147.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC pays out 331.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Bain Capital Specialty Finance has increased its dividend for 4 consecutive years and Crescent Capital BDC has increased its dividend for 1 consecutive years. Bain Capital Specialty Finance is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Bain Capital Specialty Finance had 1 more articles in the media than Crescent Capital BDC. MarketBeat recorded 1 mentions for Bain Capital Specialty Finance and 0 mentions for Crescent Capital BDC. Bain Capital Specialty Finance's average media sentiment score of 0.92 beat Crescent Capital BDC's score of 0.00 indicating that Bain Capital Specialty Finance is being referred to more favorably in the media.

Company	Overall Sentiment
Bain Capital Specialty Finance	Positive
Crescent Capital BDC	Neutral

Bain Capital Specialty Finance has higher earnings, but lower revenue than Crescent Capital BDC. Bain Capital Specialty Finance is trading at a lower price-to-earnings ratio than Crescent Capital BDC, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bain Capital Specialty Finance	$88.67M	9.07	$98.76M	$1.14	10.87
Crescent Capital BDC	$167.29M	2.41	$34.51M	$0.41	26.66

Bain Capital Specialty Finance has a net margin of 27.00% compared to Crescent Capital BDC's net margin of 9.26%. Bain Capital Specialty Finance's return on equity of 10.44% beat Crescent Capital BDC's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bain Capital Specialty Finance	27.00%	10.44%	4.35%
Crescent Capital BDC	9.26%	9.34%	4.04%

Summary

Bain Capital Specialty Finance beats Crescent Capital BDC on 12 of the 18 factors compared between the two stocks.

How does Crescent Capital BDC compare to Goldman Sachs BDC?

Crescent Capital BDC (NASDAQ:CCAP) and Goldman Sachs BDC (NYSE:GSBD) are both small-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, media sentiment, earnings, analyst recommendations, risk, institutional ownership and dividends.

In the previous week, Goldman Sachs BDC had 5 more articles in the media than Crescent Capital BDC. MarketBeat recorded 5 mentions for Goldman Sachs BDC and 0 mentions for Crescent Capital BDC. Goldman Sachs BDC's average media sentiment score of 0.79 beat Crescent Capital BDC's score of 0.00 indicating that Goldman Sachs BDC is being referred to more favorably in the news media.

Company	Overall Sentiment
Crescent Capital BDC	Neutral
Goldman Sachs BDC	Positive

Goldman Sachs BDC has a net margin of 21.32% compared to Crescent Capital BDC's net margin of 9.26%. Goldman Sachs BDC's return on equity of 10.94% beat Crescent Capital BDC's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Crescent Capital BDC	9.26%	9.34%	4.04%
Goldman Sachs BDC	21.32%	10.94%	4.66%

Crescent Capital BDC presently has a consensus price target of $13.90, suggesting a potential upside of 27.17%. Goldman Sachs BDC has a consensus price target of $8.50, suggesting a potential downside of 1.31%. Given Crescent Capital BDC's stronger consensus rating and higher possible upside, equities research analysts clearly believe Crescent Capital BDC is more favorable than Goldman Sachs BDC.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Crescent Capital BDC	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Goldman Sachs BDC	3 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.57

49.5% of Crescent Capital BDC shares are owned by institutional investors. Comparatively, 28.7% of Goldman Sachs BDC shares are owned by institutional investors. 1.2% of Crescent Capital BDC shares are owned by insiders. Comparatively, 0.1% of Goldman Sachs BDC shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Crescent Capital BDC pays an annual dividend of $1.36 per share and has a dividend yield of 12.4%. Goldman Sachs BDC pays an annual dividend of $1.28 per share and has a dividend yield of 14.9%. Crescent Capital BDC pays out 331.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Goldman Sachs BDC pays out 196.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Crescent Capital BDC has increased its dividend for 1 consecutive years. Goldman Sachs BDC is clearly the better dividend stock, given its higher yield and lower payout ratio.

Goldman Sachs BDC has higher revenue and earnings than Crescent Capital BDC. Goldman Sachs BDC is trading at a lower price-to-earnings ratio than Crescent Capital BDC, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Crescent Capital BDC	$167.29M	2.41	$34.51M	$0.41	26.66
Goldman Sachs BDC	$365.57M	2.65	$119.27M	$0.65	13.25

Crescent Capital BDC has a beta of 0.52, indicating that its share price is 48% less volatile than the broader market. Comparatively, Goldman Sachs BDC has a beta of 0.57, indicating that its share price is 43% less volatile than the broader market.

Summary

Goldman Sachs BDC beats Crescent Capital BDC on 12 of the 19 factors compared between the two stocks.

Get Crescent Capital BDC News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CCAP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CCAP vs. The Competition

Export

Metric	Crescent Capital BDC	Capital Markets Industry	Finance Sector	NASDAQ Exchange
Market Cap	$402.77M	$5.50B	$13.65B	$12.46B
Dividend Yield	12.44%	7.50%	5.95%	10.03%
P/E Ratio	26.66	36.77	28.66	24.53
Price / Sales	2.41	1,129.60	468.01	92.60
Price / Cash	6.37	84.88	44.50	46.71
Price / Book	0.57	3.68	3.68	6.07
Net Income	$34.51M	$417.14M	$1.31B	$348.23M
7 Day Performance	N/A	7.75%	3.63%	-0.42%
1 Month Performance	-1.71%	-1.25%	0.07%	-4.80%
1 Year Performance	-22.54%	5.61%	12.94%	18.61%

Crescent Capital BDC Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CCAP Crescent Capital BDC	4.9118 of 5 stars	$10.93 flat	$13.90 +27.2%	-22.5%	$402.77M	$167.29M	26.66	N/A
CGBD Carlyle Secured Lending	3.9645 of 5 stars	$10.34 +1.3%	$12.50 +20.9%	-27.1%	$718.63M	$255.57M	14.56	N/A	News Coverage Positive News Upcoming Earnings
MFIC MidCap Financial Investment	2.8939 of 5 stars	$9.85 +2.7%	$11.46 +16.4%	-22.6%	$811.34M	$320.88M	246.31	N/A	News Coverage Upcoming Earnings
SLRC SLR Investment	3.7432 of 5 stars	$12.96 +0.2%	$14.10 +8.8%	-20.8%	$707.10M	$218.54M	7.90	N/A	Upcoming Earnings Analyst Downgrade High Trading Volume
BCSF Bain Capital Specialty Finance	1.7148 of 5 stars	$12.84 +2.1%	$14.00 +9.1%	-15.8%	$832.61M	$273.24M	11.26	1,000	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CCAP) was last updated on 8/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Crescent Capital BDC (CCAP) Competitors

CCAP vs. CGBD, MFIC, SLRC, BCSF, and GSBD

How does Crescent Capital BDC compare to Carlyle Secured Lending?

Summary

How does Crescent Capital BDC compare to MidCap Financial Investment?

Summary

How does Crescent Capital BDC compare to SLR Investment?

Summary

How does Crescent Capital BDC compare to Bain Capital Specialty Finance?

Summary

How does Crescent Capital BDC compare to Goldman Sachs BDC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCAP vs. The Competition

Crescent Capital BDC Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Crescent Capital BDC (CCAP) Competitors

CCAP vs. CGBD, MFIC, SLRC, BCSF, and GSBD

How does Crescent Capital BDC compare to Carlyle Secured Lending?

Is CGBD or CCAP a better dividend stock?

Is CGBD or CCAP more profitable?

Does the media favor CGBD or CCAP?

Which has more risk & volatility, CGBD or CCAP?

Do insiders & institutionals believe in CGBD or CCAP?

Which has stronger earnings & valuation, CGBD or CCAP?

Do analysts recommend CGBD or CCAP?

Summary

How does Crescent Capital BDC compare to MidCap Financial Investment?

Does the media prefer CCAP or MFIC?

Is CCAP or MFIC more profitable?

Do institutionals & insiders have more ownership in CCAP or MFIC?

Do analysts rate CCAP or MFIC?

Which has higher valuation & earnings, CCAP or MFIC?

Which has more risk & volatility, CCAP or MFIC?

Is CCAP or MFIC a better dividend stock?

Summary

How does Crescent Capital BDC compare to SLR Investment?

Which has better earnings & valuation, CCAP or SLRC?

Do insiders & institutionals believe in CCAP or SLRC?

Do analysts recommend CCAP or SLRC?

Which has more volatility & risk, CCAP or SLRC?

Is CCAP or SLRC a better dividend stock?

Does the media prefer CCAP or SLRC?

Is CCAP or SLRC more profitable?

Summary

How does Crescent Capital BDC compare to Bain Capital Specialty Finance?

Which has more risk & volatility, BCSF or CCAP?

Do analysts prefer BCSF or CCAP?

Do insiders & institutionals believe in BCSF or CCAP?

Is BCSF or CCAP a better dividend stock?

Does the media refer more to BCSF or CCAP?

Which has preferable valuation and earnings, BCSF or CCAP?

Is BCSF or CCAP more profitable?

Summary

How does Crescent Capital BDC compare to Goldman Sachs BDC?

Does the media favor CCAP or GSBD?

Is CCAP or GSBD more profitable?

Do analysts rate CCAP or GSBD?

Do institutionals and insiders believe in CCAP or GSBD?

Is CCAP or GSBD a better dividend stock?

Which has higher valuation & earnings, CCAP or GSBD?

Which has more volatility and risk, CCAP or GSBD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCAP vs. The Competition

Crescent Capital BDC Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools